{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:27:38Z","timestamp":1762842458930,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100438","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:37:36Z","timestamp":1626482256000},"page":"100438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["De-escalating treatment for ductal carcinoma in situ \u2013 Has the pendulum swung too far? (Invited Opinion)"],"prefix":"10.1016","volume":"28","author":[{"given":"Michael","family":"Co","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2021.100438_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/prm2.12008","article-title":"Ductal carcinoma in situ of the breasts - Over-diagnosis, over-treatment and a decade of lost direction","volume":"9","author":"Co","year":"2020","journal-title":"Precis. Med. Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100438_bib0002","first-page":"486","article-title":"Clinical outcomes of patients with ductal carcinoma in situ in Hong Kong: 10-year territory-wide cancer registry study","volume":"26","author":"Co","year":"2020","journal-title":"Hong Kong MeWd J"},{"key":"10.1016\/j.ctarc.2021.100438_bib0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M15-0964","article-title":"Variability in pathologists\u2019 interpretations of individual breast biopsy slides: a population perspective","volume":"164","author":"Elmore","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100438_bib0004","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.asjsur.2019.04.015","article-title":"Co-existing malignant lesions in atypical ductal hyperplasia - Pathology, probability, predictors and prognosis","volume":"43","author":"Co","year":"2020","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.ctarc.2021.100438_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijsu.2017.11.005","article-title":"Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies \u2013 a 10-year retrospective study and review of the literature","volume":"40","author":"Co","year":"2018","journal-title":"Int. J.Surg."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100438_bib0006","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2021.100438_bib0007","first-page":"17","article-title":"Ductal carcinoma in situ of the breast - long term results from a twenty-year cohort","volume":"14","author":"Co","year":"2018","journal-title":"Cancer Treat. Res. Commun."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100438_bib0008","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study","volume":"150","author":"Sagara","year":"2015","journal-title":"JAMA Surg."},{"issue":"33","key":"10.1016\/j.ctarc.2021.100438_bib0009","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ecog-acrin e5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2021.100438_bib0010","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/1097-0142(19930315)71:6<2020::AID-CNCR2820710616>3.0.CO;2-#","article-title":"Mammographic assessment of human breast cancer growth and duration","volume":"71","author":"Spratt","year":"1993","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100438_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv372","article-title":"Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis","volume":"108","author":"Ryser","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"16","key":"10.1016\/j.ctarc.2021.100438_bib0012","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100438_bib0013","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100438_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The comparison of operative versus monitoring and endocrine therapy trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctarc.2021.100438_bib0015","article-title":"Long-term survival outcomes of 'low risk' ductal carcinoma in situ from a territory-wide cancer registry [published online ahead of print, 2020 Jul 23]","author":"Co","year":"2020","journal-title":"Clin. Oncol. (R Coll Radiol)"},{"key":"10.1016\/j.ctarc.2021.100438_bib0016","article-title":"Non-surgical treatment for ductal carcinoma in situ of the breasts - a prospective study on patient's perspective","volume":"26","author":"Co","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100438_bib0017","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1634\/theoncologist.2012-0376","article-title":"Long-term risk perceptions of women with ductal carcinoma in situ","volume":"18","author":"Ruddy","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ctarc.2021.100438_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2009.01.004","article-title":"Perceptions of ductal carcinoma in situ (DCIS) among UK health professionals","volume":"18","author":"Kennedy","year":"2009","journal-title":"Breast"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:22:49Z","timestamp":1762842169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":18,"alternative-id":["S2468294221001350"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100438","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-escalating treatment for ductal carcinoma in situ \u2013 Has the pendulum swung too far? (Invited Opinion)","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100438"}}